跳至主要内容
临床试验/JPRN-UMIN000002105
JPRN-UMIN000002105未知1 期

Clinical trial for effectiveness and safety of WT1 peptide-pulsed allogeneic dendritic cell therapy for childhood patients with chemotherapy-resistant leukemia. - Allogeneic dendritic cell therapy for pediatric leukemia.

Department of Pediatrics, Shinshu University School of Medicine0 个研究点目标入组 3 人开始时间: 2009年6月23日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 20years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patient with refractory GVHD. 2.Patient with active infections. 3.Patient wit thrombotic microangiopathy. 4.Patient with hepatic vein thrombosis. 5.Patient with early relapse. 6.Patient with mental, or familial, or geographycal obstacles to perform the trial. 7.Patient who is judged by the physician as not to be appropriate for the therapy.

研究者

发起方
Department of Pediatrics, Shinshu University School of Medicine

相似试验